Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $64,958 - $74,592
2,509 Added 22.82%
13,502 $374,000
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $22,497 - $29,222
-861 Reduced 7.26%
10,993 $316,000
Q3 2023

Nov 06, 2023

BUY
$32.09 - $37.51 $18,740 - $21,905
584 Added 5.18%
11,854 $393,000
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $25,825 - $29,879
715 Added 6.77%
11,270 $413,000
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $7,247 - $9,435
-184 Reduced 1.71%
10,555 $430,000
Q4 2022

Feb 03, 2023

BUY
$41.75 - $54.5 $3,799 - $4,959
91 Added 0.85%
10,739 $550,000
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $31,594 - $38,569
722 Added 7.27%
10,648 $466,000
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $461,856 - $547,617
9,926 New
9,926 $520,000
Q3 2021

Nov 03, 2021

SELL
$39.25 - $50.42 $251,671 - $323,293
-6,412 Closed
0 $0
Q4 2020

Jan 25, 2021

BUY
$33.47 - $42.56 $301 - $383
9 Added 0.14%
6,412 $234,000
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $6,032 - $7,077
-190 Reduced 2.88%
6,403 $235,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $272,164 - $330,175
-9,036 Reduced 57.82%
6,593 $216,000
Q1 2020

Apr 30, 2020

BUY
$27.03 - $38.62 $63,682 - $90,988
2,356 Added 17.75%
15,629 $510,000
Q4 2019

Feb 26, 2020

BUY
$32.92 - $37.36 $77,888 - $88,393
2,366 Added 21.69%
13,273 $520,000
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $385,786 - $500,251
-11,874 Reduced 52.12%
10,907 $397,000
Q2 2019

Aug 02, 2019

BUY
$36.98 - $41.52 $842,441 - $945,867
22,781 New
22,781 $987,000
Q3 2017

Nov 15, 2017

SELL
$31.0 - $34.15 $246,512 - $271,560
-7,952 Closed
0 $0
Q2 2017

Aug 10, 2017

BUY
N/A
7,952
7,952 $267,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital Wealth Planning, LLC Portfolio

Follow Capital Wealth Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Planning, LLC with notifications on news.